Transplantation Clinical Trials

82 clinical trials for Transplantation across international registries, including 20 currently recruiting participants. Compare status, phase, eligibility criteria and locations.

• International (Pediatric) Peritoneal Biobank — RECRUITING
• Transplant Wellness Program — RECRUITING · NA
• Effect of Breathing Exercise on Pain and Quality of Recovery in After Transplantation Patients: A Randomized Controlled Trial — RECRUITING · NA
• Safety and Early Efficacy of iPSC-Derived Motor Neuron Progenitor Cells (XS228) in Subacute Spinal Cord Injury: A Phase I Trial — RECRUITING · PHASE1
• Clinical Study of Venetoclax Combined With Azacitidine as Bridging Therapy Prior to Hematopoietic Stem Cell Transplantation in Patients With Higher-Risk Myelodysplastic Syndromes — RECRUITING · PHASE2
• Qualitative and Quantitative Evaluation of Vascular Flows of Radial, Ulnar and Interdigital Arterial Trees Under Normal and Pathological Conditions by 3 Tesla MRI — RECRUITING · NA
• Psychological Impact of Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation on Donors — RECRUITING · NA
• Digital Delivery of Person-centered Transitional Care — RECRUITING · NA
• PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, WITH CROSS-OVER, OF POSOLEUCEL (ALVR105) FOR THE TREATMENT OF ADENOVIRUS INFECTION IN PEDIATRIC AND ADULT PARTICIPANTS RECEIVING STANDARD OF CARE FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION — RECRUITING · PHASE3
• EARLY INITIATION OF ANTIPLATELET THERAPY IN HEART TRANSPLANTATION (AERIAL) — RECRUITING
• A RANDOMIZED TRIAL OF LOW VERSUS MODERATE EXPOSURE BUSULFAN FOR INFANTS WITH SEVERE COMBINED IMMUNODEFICIENCY (SCID) RECEIVING TCR¿¿+/CD19+ DEPLETED TRANSPLANTATION: A PHASE II STUDY BY THE PRIMARY IMMUNE DEFICIENCY TREATMENT CONSORTIUM (PIDTC) AND PEDIATRIC TRANSPLANTATION & CELLULAR THERAPY CONSORTIUM (PTCTC) PIDTC ¿CSIDE¿ PROTOCOL (CONDITIONING SCID INFANTS DIAGNOSED EARLY) PTCTC NMD1801 — RECRUITING · PHASE2
• CALCINEURIN INHIBITORS IN NEUROLOGICALLY DECEASED DONORS TO DECREASE KIDNEY DELAYED GRAFT FUNCTION (CINERGY)-PILOT — RECRUITING
• A RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CINRYZE (C1 ESTERASE INHIBITOR (HUMAN)) FOR THE TREATMENT OF ACUTE ANTIBODY-MEDIATED REJECTION (AMR) IN KIDNEY TRANSPLANT PATIENTS — RECRUITING
• ALLOGENEIC ISLET CELLS TRANSPLANTED INTO THE OMENTUM — RECRUITING
• RANDOMIZED CONTROLLED TRIAL OF INFLIXIMAB INDUCTION THERAPY FOR DECEASED DONOR KIDNEY TRANSPLANT RECIPIENTS — RECRUITING
• A SINGLE CENTRE STUDY OF THE FEASIBILITY AND SAFETY OF USING EX-VIVO NORMOTHERMIC MACHINE PERFUSION WITH THE METRA DEVICE TO STORE HUMAN LIVERS FOR TRANSPLANTATION — RECRUITING
• ASSESSING THE SAFETY AND EFFICACY OF THE GASTRIC SUBMUCOSAL SPACE IN ISLET TRANSPLANTATION — RECRUITING
• "A STUDY TO EVALUATE THE USE OF GALA, VASCULAR CONDUIT PRESERVATION SOLUTION IN PATIENTS UNDERGOING CABG. GALA SOLUTION (SOMVC001) FOR THE PRESERVATION, STORAGE AND FLUSHING OF SAPHENOUS VEIN GRAFTS." — RECRUITING
• A RANDOMIZED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTI-CENTER STUDY OF ECULIZUMAB FOR THE PREVENTION OF DELAYS GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION IN ADULT SUBJECTS AT INCREASED RISK OF DELAYED GRAFT FUNCTION — RECRUITING
• A PHASE III OPEN-LABEL TRIAL OF CASPOFUNGIN VS. AZOLE PROPHYLAXIS FOR PATIENTS AT HIGH-RISK FOR INVASIVE FUNGAL INFECTIONS (IFI) FOLLOWING ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION (HCT) — RECRUITING · PHASE3
• Evaluation of the benefits of Administering immunosuppressive drugs as Single daily doses over the first Year after liver transplantation — TERMINATED · PHASE4
• Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. — COMPLETED · PHASE2
• Efficacy of iPSC-Derived Motor Neuron Cells (XS228) in Subacute Spinal Cord Injury: A Phase II Randomized Controlled Trial — NOT_YET_RECRUITING · PHASE2
• Effect of Intraoperative Music on Inflammatory Response in Donor Hepatectomy — COMPLETED · NA
• Pharmacokinetic Study of Adoport® (Tacrolimus) in Patients With de Novo Kidney Transplantation — COMPLETED · PHASE4
• Specific Genotypes/Phenotypes of Pneumocystis Jirovecii in Solid Organ Transplant Recipients: Potential Involvement of Mycophenolic Acid — COMPLETED
• Observational Study on the Variation of Ascorbic Acid in Patients Undergoing Solid Organ Transplantation — ACTIVE_NOT_RECRUITING
• Uterus Transplantation From Deceased Donor - Gothenburg III — COMPLETED · NA
• Acute Pharmacokinetic-pharmacodynamic Change of Rocuronium After Reperfusion of Renal Graft — OTHER · NA
• Transplantation of Vaginal Mikrobiome — COMPLETED · NA
• Vaccines Immunogenicity in Renal, Hepatic, Cardiac or Pulmonary Transplanted Children — COMPLETED · NA
• Precision Medicine Offers Belatacept Monotherapy — WITHDRAWN · PHASE4
• Comparison of Two Techniques of Renal Pre-transplant Infusion on the Evolution of Renal Function in the Recipient — COMPLETED
• Benefits of Exercise Program in Pediatric HSCT — COMPLETED · NA
• PD-1 Inhibitor Tislelizumab Maintenance Therapy in Newly Diagnosed DLBCL Patients After ASCT — OTHER · PHASE3
• Assessment of the Impact of COVID-19 on Transplant Patients and on Patients Awaiting Transplantation — COMPLETED
• PD-1 Inhibitor Tislelizumab Maintenance Therapy in R/R DLBCL Patients After ASCT — OTHER · PHASE3
• mHealth Family Self-Management — COMPLETED · NA
• Functional Genetic Variants Affecting Tacrolimus Trough Levels and Side Effects in Chinese Renal Transplantation. — COMPLETED
• Low-dose IL-2 for Treg Expansion and Tolerance (LITE) — TERMINATED · PHASE4
• National Observational Study of Clinical Practices in Deceased Organ Donation — COMPLETED
• Retrospective Non-interventional Analysis of Opportunistic Infections in Immunocompromised and Frail Patients — OTHER
• A SINGLE CENTRE PILOT STUDY OF USING DONATION AFTER CIRCULATORY DEATH HEARTS FOR TRANSPLANTATION USING NORMOTHERMIC MACHINE PERFUSION FOR THE PRESERVATION AND EVALUATION OF HUMAN HEARTS PRIOR TO TRANSPLANTATION — NOT_YET_RECRUITING
• Influence of Pantoprazole on the Bioavailability of MMF and EC-MPS — COMPLETED · PHASE4
• PHARMACOKINETICS AND SAFETY OF APIXABAN AND TACROLIMUS OR CYCLOSPORINE IN KIDNEY AND LUNG TRANSPLANT RECIPIENTS. — NOT_YET_RECRUITING
• TRANSPLANTATION USING HEPATITIS C POSITIVE DONORS TO HEPATITIS C NEGATIVE RECIPIENTS: A SAFETY TRIAL — NOT_YET_RECRUITING
• PHASE III MULTI-CENTER OPEN LABEL RANDOMIZED CLINICAL TRIAL COMPARING EVEROLIMUS AND LOW DOSE TACROLIMUS TO TACROLIMUS AND MYCOPHENOLATE MOFETIL AT 6MONTHS POST HEART TRANSPLANT TO PREVENT LONG-TERM COMPLICATIONS AFTER PEDIATRIC HEART TRANSPLANTATION — NOT_YET_RECRUITING · PHASE3
• Monitoring Organ Donors to Increase Transplantation Results (MOnIToR) — COMPLETED · NA
• EARLY POST TRANSPLANT CARDIAC ALLOGRAFT VASCULOPATHY (ECAV) — NOT_YET_RECRUITING
• Donor Simvastatin Treatment in Organ Transplantation — COMPLETED · PHASE2

Refine this search